Search Results - "Itti, E"

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL) by Cottereau, A.S., Becker, S., Broussais, F., Casasnovas, O., Kanoun, S., Roques, M., Charrier, N., Bertrand, S., Delarue, R., Bonnet, C., Hustinx, R., Gaulard, P., de Leval, L., Vera, P., Itti, E., Mounier, N., Haioun, C., Tilly, H., Meignan, M.

“…Most peripheral T-cell lymphoma (PTCL) patients have a poor outcome and the identification of prognostic factors at diagnosis is needed. The prognostic impact…”
Get full text

High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study by Villafane, G., Thiriez, C., Audureau, E., Straczek, C., Kerschen, P., Cormier‐Dequaire, F., Van Der Gucht, A., Gurruchaga, J.‐M., Quéré‐Carne, M., Evangelista, E., Paul, M., Defer, G., Damier, P., Remy, P., Itti, E., Fénelon, G.

“…Background and purpose Studies of the effects of nicotine on motor symptoms in Parkinson's disease (PD) brought out discordant results. The aim of the present…”
Get full text

Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria by Ghosn, M., Derbel, H., Kharrat, R., Oubaya, N., Mulé, S., Chalaye, J., Regnault, H., Amaddeo, G., Itti, E., Luciani, A., Kobeiter, H., Tacher, V.

“…•RECIST 1.1, mRECIST and EASL predict overall survival of patients with hepatocellular carcinoma treated with transarterial Y90 radioembolization.•Quantitative…”
Get full text

Severe posterior hypometabolism but normal perfusion in a patient with chronic fatigue syndrome/myalgic encephalomyelitis revealed by PET/MRI by Sahbai, S., Kauv, P., Abrivard, M., Blanc-Durand, P., Aoun-Sebati, M., Emsen, B., Luciani, A., Hodel, J., Authier, F-J., Itti, E.

Get full text

EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B‐CELL LYMPHOMA : RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY by Delfau‐Larue, M., Viailly, P., Cartron, G., Morschhauser, F., Gros, F., Gastinne, T., Oberic, L., Bachy, E., Dulery, R., Feugier, P., Menard, C., Quelen, C., Pangault, C., Portugues, C., Gomes, L., Itti, E., Bailly, C., Lemonnier, F., Laurent, C., Houot, R.

Get full text

AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY by Houot, R., Bachy, E., Cartron, G., Gros, F., Morschhauser, F., Oberic, L., Gastinne, T., Feugier, P., Dulery, R., Thieblemont, C., Joris, M., Jardin, F., Choquet, S., Casasnovas, O., Brisou, G., Cheminant, M., Bay, J., Gutierrez, F. Llamas, Menard, C., Tarte, K., Delfau, M., Itti, E., Bailly, C., Al Tabaa, Y., Laurent, C., Lemonnier, F.

Get full text

ROMIDEPSIN PLUS CHOP VERSUS CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA: FINAL ANALYSIS OF THE RO‐CHOP TRIAL by Camus, V., Thieblemont, C., Gaulard, P., Cheminant, M., Casasnovas, R., Ysebaert, L., Damaj, G. L., Guidez, S., Pica, G. M., Kim, W. S., Lim, S. T., Andre, M., Gutiérrez, N., Penarrubia, M. J., Staber, P. B., Trotman, J., Hüttmann, A., Stefoni, V., Rossi, G., Delfau‐Larue, M., Cottereau, A., Itti, E., Li, J., Delarue, R., Leval, L., Morschhauser, F., Bachy, E.

Get full text

Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial by Sobhani, I., Itti, E., Luciani, A., Baumgaertner, I., Layese, R., André, T., Ducreux, M., Gornet, J.-M., Goujon, G., Aparicio, T., Taieb, J., Bachet, J.-B., Hemery, F., Retbi, A., Mons, M., Flicoteaux, R., Rhein, B., Baron, S., Cherrak, I., Rufat, P., Le Corvoisier, P., de’Angelis, N., Natella, P.-A., Maoulida, H., Tournigand, C., Durand Zaleski, I., Bastuji-Garin, S.

“…[18F]2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (18FDG-PET/CT) has high sensitivity for detecting recurrences of colorectal…”
Get full text

CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON‐BURKITT) B‐CELL LYMPHOMA IN A REAL LIFE COHORT by Roulin, L., Jais, J., Poullot, E., Robe, C., Scherman, E., Lemonnier, F., Le Bras, F., Maarek, A., Belhadj, K., Dupuis, J., Hammoud, M., El Gnaoui, T., Mule, S., Itti, E., Delfau‐Larue, M., Gaulard, P., Haioun, C., Copie‐Bergman, C.

Get full text

Neuropsychological correlates of brain perfusion SPECT abnormalities in patients with macrophagic myofasciitis by Van der Gucht, A, Aoun Sebati, M, Itti, E, Aouizerate, J, Bachoud, A, Authier, F

Get full text

Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging by Legou, F, Tacher, V, Damy, T, Planté-Bordeneuve, V, Rappeneau, S, Benhaiem, N, Rosso, J, Itti, E, Luciani, A, Kobeiter, H, Rahmouni, A, Deux, J.-F

“…Abstract Purpose To detect if a difference of T2 ratio, defined as the signal intensity (SI) of the myocardium divided by the SI of the skeletal muscle on…”
Get full text

Tangential Fields (TgFs) Breast Radiation Therapy (RT): Prospective Evaluation of the Dose Distribution in the Axilla and the Sentinel Lymph Node Area (SLNA) Determined Intraoperatively by Clip Placement by Belkacemi, Y, Bigorie, V, Pan, Q, Bosc, R, Bouaita, R, Pigneur, F, Guet, S, Badaoui, H, Assaf, E, Caillet, P, Itti, E, Calitchi, E

Get full text

Dual-tracer 18F-fluorocholine and 18F-fluorodeoxyglucose PET/CT for the diagnosis of tumoral portal vein thrombosis in patients with hepatocellular carcinoma by Chalaye, J, Baranes, L, Costentin, C, Lim, C, Herin, E, Calderaro, J, Rahmouni, A, Azoulay, D, Itti, E, Luciani, A

Get full text

The Structural Brain Correlates of Cognitive Deficits in Adults with Klinefelter’s Syndrome by Itti, E., Gaw Gonzalo, I. T., Pawlikowska-Haddal, A., Boone, K. B., Mlikotic, A., Itti, L., Mishkin, F. S., Swerdloff, R. S.

“…Context: Adults with Klinefelter’s syndrome (KS) are known to present disturbances of language skills and delayed learning abilities. Objectives: The aim of…”
Get full text

BASELINE CIRCULATING CELL‐FREE DNA LOAD IS RELATED TO, BUT ADDS PROGNOSTIC VALUE TO METABOLIC TUMOR BURDEN MEASURED BY FDG PET/CT IN FOLLICULAR LYMPHOMA by Delfau‐Larue, M.H., Benmaad, I., Robert, P., Hamdane, S., Nel, I., Dupuis, J., Haioun, C., Berriolo Riedinger, A., Casasnovas, R.O., Itti, E.

Get full text

Whole-body diffusion-weighted imaging in lymphoma by Lin, C, Itti, E, Luciani, A, Haioun, C, Meignan, M, Rahmouni, A

“…The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (DWI) in lymphoma is reviewed. DWI is capable of…”
Get full text

627 ROLE OF FDG PET IN PATIENTS WAITING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA by Decaens, T, Itti, E, Laurent, A, Luciani, A, Tran Van Nhieu, J, Auriault, M.-L, Evangelista, E, Meignan, M, Azoulay, D, Duvoux, C

Get full text

RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION by Cazelles, C., Belhadj, K., Vellemans, H., Camus, V., Copi‐Bergman, C., Veresezan, L., Itti, E., Becker, S., Carvalho, M., Dupuis, J., Fabien, L., Lemonnier, F., Roulin, L., El Gnaoui, T., Jardin, F., Mounier, N., Tilly, H., Haioun, C.

Get full text

Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria by Dupuis, J., Itti, E., Rahmouni, A., Hemery, F., Gisselbrecht, C., Lin, C., Copie-Bergman, C., Belhadj, K., El Gnaoui, T., Gaillard, I., Kuhnowski, F., Meignan, M., Haioun, C.

“…Background: Revised response criteria for aggressive lymphomas have been proposed (Cheson, J Clin Oncol, 2007) stressing the role of…”
Get full text

28 PILOT STUDY OF SIROLIMUS IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA by Decaens, T, Luciani, A, Itti, E, Hulin, A, Hurtova, M, Laurent, A, Cherqui, D, Mallat, A, Duvoux, C

Get full text